GE HealthCare Technologies Inc. (NASDAQ:GEHC) Receives Average Recommendation of “Hold” from Brokerages

GE HealthCare Technologies Inc. (NASDAQ:GEHC) has been assigned a consensus recommendation of “Hold” from the fourteen brokerages that are currently covering the company, MarketBeat reports. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and seven have assigned a buy rating to the company. The average 12 month price target among brokerages that have issued ratings on the stock in the last year is $92.50.

Several analysts have weighed in on GEHC shares. Wells Fargo & Company lifted their price objective on shares of GE HealthCare Technologies from $95.00 to $97.00 and gave the stock an “overweight” rating in a research note on Thursday, February 5th. Bank of America lifted their price target on shares of GE HealthCare Technologies from $82.00 to $92.00 and gave the company a “neutral” rating in a research report on Monday, January 5th. BTIG Research boosted their price target on GE HealthCare Technologies from $87.00 to $91.00 and gave the company a “buy” rating in a research note on Wednesday, February 4th. Evercore lifted their price objective on GE HealthCare Technologies from $95.00 to $98.00 and gave the company an “outperform” rating in a report on Thursday, February 5th. Finally, The Goldman Sachs Group reiterated a “buy” rating and set a $98.00 target price on shares of GE HealthCare Technologies in a research report on Friday, January 9th.

GE HealthCare Technologies Stock Performance

NASDAQ:GEHC opened at $78.13 on Wednesday. The stock has a 50 day simple moving average of $82.20 and a 200 day simple moving average of $78.54. The stock has a market cap of $35.61 billion, a P/E ratio of 17.13, a PEG ratio of 1.76 and a beta of 1.03. GE HealthCare Technologies has a 1-year low of $57.65 and a 1-year high of $89.77. The company has a current ratio of 1.37, a quick ratio of 1.13 and a debt-to-equity ratio of 0.91.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, February 4th. The company reported $1.44 earnings per share for the quarter, topping the consensus estimate of $1.40 by $0.04. The firm had revenue of $5.70 billion for the quarter, compared to analysts’ expectations of $5.60 billion. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The company’s quarterly revenue was up 7.1% compared to the same quarter last year. During the same quarter last year, the business earned $1.45 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Research analysts anticipate that GE HealthCare Technologies will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Friday, April 3rd will be given a dividend of $0.035 per share. The ex-dividend date of this dividend is Thursday, April 2nd. This represents a $0.14 annualized dividend and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is currently 3.07%.

Hedge Funds Weigh In On GE HealthCare Technologies

Several hedge funds and other institutional investors have recently made changes to their positions in GEHC. Empowered Funds LLC increased its stake in GE HealthCare Technologies by 6.1% in the first quarter. Empowered Funds LLC now owns 28,848 shares of the company’s stock valued at $2,328,000 after acquiring an additional 1,665 shares during the last quarter. Acadian Asset Management LLC bought a new position in shares of GE HealthCare Technologies in the 1st quarter valued at $259,000. Assetmark Inc. raised its holdings in shares of GE HealthCare Technologies by 46.0% during the 2nd quarter. Assetmark Inc. now owns 9,107 shares of the company’s stock worth $675,000 after buying an additional 2,868 shares in the last quarter. Sigma Planning Corp lifted its position in shares of GE HealthCare Technologies by 17.9% during the 2nd quarter. Sigma Planning Corp now owns 7,057 shares of the company’s stock worth $523,000 after buying an additional 1,071 shares during the last quarter. Finally, Key Financial Inc boosted its stake in GE HealthCare Technologies by 34.2% in the second quarter. Key Financial Inc now owns 1,252 shares of the company’s stock valued at $93,000 after buying an additional 319 shares in the last quarter. 82.06% of the stock is currently owned by institutional investors and hedge funds.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.